Intersecting Pandemics of Epidemiology,Inequality,Genetics,and Immunology: COVID-19 and AIDS

Byanyima W. Preparatory meeting of the Global Fund's seventh replenishment. February 23, 2022. Available at: https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2022/february/20220223_seventh-replenishment

Laurence J . Why aren't people living with HIV at higher risk for developing severe coronavirus disease 19 (COVID-19)?. AIDS Patient Care STDs, 2020; 34:247–248.

Johnston R . The first 6 months of HIV-SARS-CoV-2 coinfection: Outcomes for 6947 individuals. Curr Opinion HIV AIDS, 2021; 16:54–62.

McMillan JM , Gill MJ , Power C , Fujiwara E , Hogan DB , Rubin LH . Comorbidities in older persons with controlled HIV infection: Correlations with frailty index subtypes. AIDS Patient Care STDs, 2020; 34:284–294.

Richardson S , Hirsch JS , Narasimhan M , et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA, 2020; 323:2052–2059.

Lodge W II , Kuchukhidze S . COVID-19, HIV, and migrant workers: The double burden of the two viruses. AIDS Patient Care STDs, 2020; 6:249–250.

Millett GA , Honermann B , Jones A , et al. White counties stand apart: The primacy of residential segregation in COVID-19 and HIV diagnoses. AIDS Patient Care STDs, 2020; 34:417–424.

Kaplan-Lewis E , Banga J , Khan M , et al. HIV diagnosis and the clinical course of COVID-19 among patients seeking care within the New York City public hospital system during the initial pandemic peak. AIDS Patient Care STDs, 2021; 35:457–466.

Tesoriero JM , Patterson W , Daskalakis D , et al. COVID-19 vaccination among persons living with diagnosed HIV infection—New York, October 2021. Morbid Mortal Weekly Rep, 2022; 71:182–184.

Zeberg H . The major genetic risk factor for severe COVID-19 is associated with protection against HIV. Proc Natl Acad Sci USA, 2022; 119:e2116435119.

Hsu J , Van Besien K , Glesby MJ , et al. HIV-1 remission with CCR5Δ32Δ32 haplo-cord transplant in a U.S. woman: IMPAACT P1107. Conference on Retroviruses and Opportunistic Infections, virtual, Feb. 12–16, 2022, Abst. 65LB.

Huffman JE , Butler-Laporte G , Khan A , et al. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. Nat Genetics, 2022; 54:125–127.

Hassold N , Brichler S , Ouedraogo E , et al. Impaired antibody response to COVID-19 vaccination in advanced HIV infection. AIDS, 2022; 36:F1–F5.

Sun J , Zheng Q , Anzalone AJ , et al. COVID-19 booster vaccine effectiveness in people with and without immune dysfunction. Conference on Retroviruses and Opportunistic Infections, virtual, Feb. 12–16, 2022, Abst. Oral-04.

Cele S , Karim F , Lustig G , et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe, 2022; 30:154–162.

Maemura T , Kuroda M , Armbrust T , Yamayoshi S , Halfmann PJ , Kawaoka Y . Antibody-dependent enhancement of SARS-CoV-2 infection is mediated by the IgG receptors FcɣRIIA and FcɣRIIIA but does not contribute to aberrant cytokine production by macrophages. mBio, 2021; 12:e01987-21.

Jaiswal J , Krause KD , Martino RJ , et al. SARS-CoV-2 vaccination hesitancy and behaviors in a national sample of people living with HIV. AIDS Patient Care STDs, 2022; 36:34–44.

Rubin R . COVID-19 vaccines have been available in the US for more than a year—What's been learned and what's next?. JAMA, 2022; 327:513–516.

Gimbel S , Kawakyu N , Dau H , Unger JA . A missing link: HIV-/AIDS-related mHealth interventions for health workers in low- and middle-income countries. Curr HIV/AIDS Rep, 2018; 15:414–422.

Auchus IC , Jaradeh K , Tang A , Marzan J , Boslett B . Transitioning to telehealth during the COVID-19 pandemic: Patient perspectives and attendance at an HIV clinic in San Francisco. AIDS Patient Care STDs, 2021; 35:249–253.

Cohn AC , Mahon BE , Walensky RP . One year of COVID-19 vaccines. A shot of hope, a dose of reality. JAMA, 2022; 327:119–120.